HCmed Innovations Co., Ltd. (TPEX:6934)
Taiwan · Delayed Price · Currency is TWD 148.50
+15.00 (11.24%)
At close: Jan 20, 2026
HCmed Innovations Company Description
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways in the United States, Europe and Asia.
The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals.
It also provides contract development and manufacturing organization services. The company was founded in 2014 and is headquartered in Taipei, Taiwan.
HCmed Innovations Co., Ltd.
| Country | Taiwan |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Jason Cheng |
Contact Details
Address: No. 319, Dunhua South Road Taipei, 106033 Taiwan | |
| Phone | 886 2 2732 6596 |
| Website | hcmed-inno.com |
Stock Details
| Ticker Symbol | 6934 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006934003 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Jason Cheng | Co-Founder, Chairman and Chief Executive Officer |
| Hsieh Simon | Co-Founder and Director |
| Tsai Leon | Co-Founder, Chief Operating Officer and Director |
| Dr. Shaogi Huang M.D. | Medical Advisor and Co-Founder |
| Wooca Tu | Chief Financial Officer |
| Wooca Tu | Accounting Supervisor |